Posted on September 3, 2018May 7, 2019Two serious adverse events associated with PEG drugs FDA investigates two serious adverse events associated with ImprimisRx’s compounded curcumin emulsion product for injection (08/04/2017)
Posted on September 2, 2018May 7, 2019Peginesatide (Omontys): Recalled due to serious hypersensitivity FDA alerts health care providers of recall of anemia drug Omontys (02/24/2013) Omontys Injection by Affymax and Takeda: Recall of All Lots – Serious Hypersensitivity Reactions (02/23/2013)
